Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-11-27

Clinical Trial Update: Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing rapid versus conventional titration of quetiapine in schizophrenia and schizoaffective disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenia, Schizoaffective Disorders | Phase 3 | Status: TERMINATED